SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (236)7/27/1998 3:49:00 PM
From: scaram(o)ucheRead Replies (1) of 4974
 
George:

Perhaps it's true that "most" biotechs do private placements.

However, very few companies that I have owned have done them. As a matter of fact, I can only think of two companies that I've owned in the past two years that have done a PP. One had already crashed, and the other did the PP just before crashing.

So..... I have probably owned 50 biotechs. I'd bet that less than five have done private placements, and I can only think of one that did such when the business plan was still healthy. I can only think of two companies that did a PP while I still owned them. Certainly, among the universe of companies that I find to be attractive, PPs are the exception not the rule.

Cheers! Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News